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Depends on Intracellular Routing Rather than on the Number of Internalized Molecules. Scand J 
Immunol 1995;41:559-65
Cytotoxicity of immunotoxins (ITs) varies considerably depending on factors like the capability of the 
target antigen to internalize IT molecules, intracellular processing and routing of the IT. We studied 
factors that may influence cytotoxicity of CD22-ricin A IT to several B cell lines. The antigen density 
varied from 5.9xlO3 to 6.0xlO4 molecules/cell. The ID 50, determined by protein synthesis inhibition, 
varied from 2 .1x l0 -12  to 3 .8 x l0 “ n M IT in absence and from 2 .8 x l0 -14  M  to 5 .2 x l0 " 12 M IT in 
presence of the cytotoxicity enhancer N H 4CI (6 mM). In absence as well as in presence of N H 4CI no 
correlation could be found between antigen density and ID 50. No relation was observed either with the 
rate of cytotoxicity. Even in cell lines with a low antigen density, such as KM3, protein synthesis was 
quickly inhibited. In order to investigate whether the cytotoxicity was dependent on the number of 
internalized molecules the kinetics of internalization and exocytosis of degraded 125I-labelled CD22 
molecules were studied. After 24h the number of internalized CD 22 molecules was highest in Ramos 
(154,500), followed by Daudi (110,300) and KM3 (69,900). However, despite the higher internalization 
rate of Daudi the rate of cytotoxicity of 10” s M IT was comparable with KM3. N H 4CI did not influence 
the number of internalized molecules but postponed degradation of CD22. In conclusion, CD22-ricin A 
is a very potent and fast acting IT even for elimination o f target cells that express low numbers of 
antigen. These results may have implication for treatment of different B cell malignancies with CD22- 
ricin A.
Peter Jan van Horssen, Department o f  Hematology, University Hospital S t Radboud, Geert Grooteplein 8, 
6525 GA Nijmegen, The Netherlands
INTRODUCTION
Ricin A chain ITs have been shown to be highly effective for 
the elimination of malignant B cells in vitro and in vivo [1].
Ricin A chain inhibits cataiytically and irreversibly protein 
synthesis by cleaving the N-glycosidic bond of a single 
adenosine residue of 28 S rRNA [2-4]. Theoretically, a 
single ricin A molecule that enters the cytosol has the 
potency to kill a cell. Since IT molecules are usually trans­
ported through cellular compartments where the ricin A may 
be either proteolytically cleaved or inactivated by low pH, 
more molecules must be endocytosed to guarantee cytotoxi­
city. The deliverance of the toxic compound of the IT into the 
cytosol depends on several factors such as the type and 
recognized epitope of the antigen, the number of internalized 
molecules [5], the intracellular routing and processing [6 , 7]
and the iso type of the monoclonal antibody (MoAb) [8]. This 
may result in a variable efficacy of the appropriate IT on 
different target cells by which the antigen is expressed and 
may complicate the treatment of different malignancies with 
ITs. The cytotoxic activity of ricin A ITs can be enhanced by 
the lysosomotropic amine N H 4CL N H 4C1 influences different 
intracellular processes such as routing and metabolism, 
enabling more ricin A molecules to reach their target without 
changing the internalization of the IT [9, 10].
We investigated the cytotoxicity of CD22-ricin A and some 
factors that influence this cytotoxic activity. The CD22 
MoAb binds the B lymphocyte cell adhesion molecule (BI­
CAM) [11, 12] that is expressed on the surface of B cells in a 
wide range of differentiation from the early pro-B-cell stage to 
the immunocyte stage [13] and on their malignant counterparts.
We studied the influence of antigen density and kinetics of
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internalization and intracellular degradation on the cytotoxic 
efficacy and the rate of activity of CD22-recombinant ricin A 
IT. This was investigated in absence and presence of N H 4CI 
in a panel of B-lineage cell lines.
M ATERIALS AND M ETH O D S
Celt lines. The B-lineage cell lines KM3 (pre-B cell), Daudi, Raji> 
Ramos, Rosl [14] (Burkitt lymphomas), DoHH2, SU-DHL-6 (folli­
cular lymphomas) and the T-lineage cell lines HPB-ALL and CEM 
were used. Cell lines were cultured in culture medium consisting of 
RPMI-1640 (Flow, Irvine, UK) supplemented with 10% heat- 
inactivated fetal calf serum (Gibco, Paisley, UK), 2 mm glutamine, 
50 U/ml penicillin and 50 ¿¿g/ml streptomycin (Flow) in a humidified 
incubator with 5% CO2 in air at 37°C. Cells were maintained in log 
phase.
Monoclonal antibody. The murine MoAb CD22 (CLB-B-ly/1) 
(IgGl) (generously provided by Dr I. Slaper, CLB, Amsterdam, 
The Netherlands) was purified from ascites fluid by ammonium 
sulphate precipitation and affinity chromatography using staphylo­
coccal protein A-Sepharose (Pharmacia, Uppsala, Sweden).
Radioiodination. The MoAb was labelled with N a125I (Amersham 
International pic, Buckinghamshire, UK) using the chloramm-T 
method [15] and purified on Sephadex G25 column (PD-10; Phar­
macia). Eluted fractions containing 12SI~IgG were pooled, and 
molecules smaller than M r 30 000 were removed by Centriprep-30 
concentration (Amicon, Beverly, MA, USA). The concentration was 
determined by Mancini assays [16] and specific binding activity was 
assessed by performing binding studies with limiting amounts of 
labelled antibody.
Immunotoxin preparation, CD22 MoAb was coupled to recombi­
nant ricin A-chain (generously provided by ZENECA Pharmaceu­
ticals, Macclesfield, UK) by means of 4-succinimidyloxylcarbonyl- 
a(2-pyridyldithio)toluene (SMPT, synthesized by the Department of 
Organic Chemistry, University of Nijmegen, The Netherlands) 
according to Thorpe et al [17]. Briefly, 10 mg CD22 (in 1 ml 25 mm 
sodium borate pH 9) was treated with a 1 0-fold molar excess of 
SMPT (110 ¡A of 1 mg/ml SMPT solved in N,N-Dirnethylformamide 
(DMF, Merck, Darmstadt, Germany)) under gently rotating during
1 h at 20°C. Free SMPT and DMF were removed by gel filtration on 
a Sephadex G25 (Pharmacia) column. To introduce a free sulphhy- 
dryl group ricin A was incubated in 50 mm DTT for 30min at 20°C. 
DTT was removed by gel filtration on the G25 column. The modified 
MoAb was incubated with a 2.5 molar excess ricin A for 72 h at 2 0 °C 
resulting in a coupling ratio (ricin A: MoAb) of 0 .8 . Free ricin A was 
separated from the IT by gel filtration on a Sephacryl S200 High 
Resolution (Pharmacia) column, The IT-product was checked by 
SDS-PAGE on gradient gels of 4 to 15% using the Pharmacia 
LKB • Phastsystem.
Antigen density. The antigen density was determined by Scatchard 
analysis. Suspensions of 5x10s cells were incubated with various 
concentrations of 125I-labelled CD22 for 2h  at 4°C (final volume 
100/ul). Before and after washing radioactivity was counted to 
determine the number of free and cell-associated molecules. N on­
specific binding to incubation tubes was assessed by performing the 
experiment in the absence of targets. The number of bound 
molecules/cell under saturating conditions was calculated according 
to Scatchard [18].
Cytotoxicity o f  CD22-ricin A . Cells (10 ) in culture medium were
incubated with various concentrations CD22-ricin A (10~ 14 to 
10“ 8 M) in the presence or absence o f 6 mM NH4CI in a final 
volume of 200 p\. Incubation was performed in 96-well microtitre 
plates (Costar, Cambridge, MA, USA) in triplicate for 24 h at 37°C. 
Subsequently, 0.5 pC i [3H]leucine (Amersham) was added. After 24 h 
cells were harvested and the radioactivity was determined. Cytotoxi- 
city was expressed as the percentage [ HJleucine incorporation 
corrected for non-specific incorporation in cells incubated in the 
presence of I mM cycloheximide (Boehringer Mannheim, Mann- 
heim, Germany), with regard to [ H]leucine incorporation in 
untreated cells corrected for non-specific incorporation.
Rate o f  cytotoxicity. Cells were incubated with 10 “ 8 M CD22-ricin 
A in culture medium for various periods of time. Thereafter cells 
were washed, resuspended in culture medium and incubated up to 
24 h after initiating the experiment. Subsequently, cells were distri- 
buted in triplicate in 96-well microtitre plates and 0.5 pCi [ H]leucine 
was added. Protein synthesis was determined as described.
Kinetics o f  binding and internalization o f !25I-CD22. The number of 
cell bound, intracellular, broken down and subsequently exocytosed 
125I-labelled MoAb molecules was determined during continuous 
incubation using a modification of a previously described procedure
[19]. Briefly, a suspension of 5xl05 cells was incubated with 10"8M 
MoAb for various times at either 37°C or 4°C in a final volume of 
100 pi. Cells were washed and radioactivity was calculated to 
determine the total amount of cell associated radioactivity. Subse­
quently, cells were incubated with isotonic glycine buffer (pH 2) at 
4°C for 30min to remove surface-bound molecules, washed, and 
radioactivity was again determined. The absolute number of intra­
cellular molecules was calculated from the glycine buffer-treated cells 
initially incubated at 37°C after correcting for radioactivity in cells 
treated similarly at 4°C.
The number of molecules bound to the cell surface was determined 
by subtracting the amount of intracellular radioactivity from the 
total radioactivity associated with cells after incubation at 37°C.
Degradation o f I25I-CD22. After incubation with labelled MoAb at 
37°C or 4QC, cells were pelleted by centrifugation. Seventy-five 
microlitres of supernatant were treated with 1 ml of 15% trichloro­
acetic acid (TCA) and 1 0 0  p\ 1% bovine serum albumine at 4°C for 
at least 15min and then centrifugated at 1500# for 15min. The 
intracellularly degraded and subsequently exocytosed amount of 
MoAb was determined by measuring radioactivity of the TCA- 
soluble fraction of culture supernatant. The radioactivity of the 
soluble fraction from cells incubated at 4°C was subtracted from 
that obtained at 37°C to remove any background radioactivity.
Internalization o f  l25I-CD22. Internalization was defined as the 
total number of molecules transported across the cell membrane and 
was calculated by summation of the amount of intracellular MoAb 
and the amount of broken down and exocytosed MoAb.
RESU LTS
Antigen density
The antigen density for 125I-labelled CD22 was determined by 
Scatchard analysis and varied between the different B cell 
lines (Table 1). The pre-B cell line K M 3 appeared to bind 
5.9xl03 CD22  molecules per cell which was seven to 10 times 
less than the more mature Burkitt (Daudi, Raji and Ramos) 
and follicular lymphoma (DoHH2 and SU-DHL-6) cell lines.
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Table 1 . CD22 antigen density in comparison with the cytotoxicity of CD22-ricin A in 
absence and in presence of 6 mM N H 4C1
Antigen density“ IT -  NH4Clb IT + NH4Clb Factor of 
Cell line 10~ 3 xmol./cell ID50 (M) ID50 (M) enhancement0
KM 3 5.9Í0.7 1.9xl0"u 3.4x10“ 3 56
Daudi 42.3 ± 8.6 4.2x10“ 12 5.1x10" 3 8
Raji 60.4± 11.1 3.4xl0"u 5.2x10" 2 7
Ramos 52.4 ¿11.8 3.5xl0 - 1 2 3.8x10" 3 9
Rosl 2 1 .0 ±  1.2 3.8xlO"u 2 .2 x1 0 " 2 17
DoHH2 52.2±8.5 5.6xl0 - 1 2 6.3x10" 4 93
SU-DHL-6 51.1 ± 1.6 2 .1x l0 “ 12 2 .8x1 0 “ 4 75
The antigen density was determined in Scatchard analysis and expressed as molecules 
per cell. Experiments were performed in duplicate and mean of three experiments is 
shown,
b Cytotoxicity of CD22-ricin A was determined in a protein synthesis inhibition assay in 
absence and in presence of 6 mM NH 4CI and expressed as ID50. Assays were performed in 
triplicate; SDs were less than 10%.
cThe factor of enhancement is the product of ID 50 in absence o f NH 4CI divided by ID 50 
in presence of NH4CI.
The Burkitt lymphoma cell line Rosl bound 21xl03 CD22 (data not shown). Concentrations up to 10” 7M CD22-ricin
molecules per cell, two to three times less than the other cell 
lines except KM3. The affinity of the MoAb on the different 
cell lines was comparable (Ka= l-3xlO“ 9 M).
Cytotoxicity of CD22-ricin A IT
CD2 2 -ricin A strongly inhibited protein synthesis in the 
different B cell lines which was determined by [3H]leucine 
incorporation. Strikingly strong cytotoxicity was found even 
for cells that express low numbers of target antigen. This 
cytotoxicity was independent on the maturation stage of the 
target cell. Cytotoxic activity, expressed by the 50% inhi­
bition dose (ID50), varied between 3.8xlO~~n M and 
2.1xlO” l2M (Table 1). Addition of 6 mM NH4C1 enhanced 
significantly the cytotoxicity of the IT. Enhancement varied 
considerably from a factor 7 in Raji to 93 in DoHH2 
suggesting a different handling of the IT. In presence of 
NH4CI the most mature follicular lymphoma cell lines 
DoHH2 and SU-DHL-6 were most sensitive for the IT,
In absence as well as in presence of NH4CI no correlation 
could be detected between antigen density and cytotoxicity of 
the IT (in both P = 0.76, Spearman’s coefficient) (Table 1, 
Fig. 1)* Although KM3, Raji and Rosl varied strongly in 
antigen expression the IDsos for these cell lines in absence of 
NH4CI were comparable (1.9-3.8xl0~n M). In contrast, in 
Daudi, Ramos, DoHH2 and SU-DHL-6 the antigen expres­
sions and ID50s were comparable. Nevertheless ID 50S in the 
presence of NH4C1 varied strongly.
IT concentrations of 10“ 8 M inhibited protein synthe­
sis only completely in Ramos, DoHH2 and SU-DHL-6 . 
However, in presence of N H 4CI 10- 8 M IT could inhibit 
protein synthesis completely in all cell lines except in Rosl
A did not reduce protein synthesis in the antigen negative 
control T cell lines HPB-ALL and CEM. No differences could 
be detected with respect to the sensitivity for unconjugated 
ricin A. The ID 50 appeared to be 4x10“ 7 M for all cell lines in 
absence as well as in presence of N H 4CI (data not shown).
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Fig. 1. Relationship between cytotoxicity of CD22-ricin A and 
antigen density. Cytotoxicity of CD22-ricin A was determined in a 
protein synthesis inhibition assay. Cells were incubated for 24 h at 
37°C with various concentrations of IT (1 0 ~ 14~ 1 0 ~ 8 M) in 
absence (A) or in presence (B) o f 6 mM N H 4C1. [3H]leucine was 
added for another 24 h whereafter the cells were harvested. Protein 
synthesis is expressed as a percentage o f [3H]leucine incorporation 
of untreated cells. Cytotoxicity is expressed as ID 50. Mean of three 
experiments which were performed in triplicate is shown; SDs were 
less than 10%. Antigen density was determined in a Scatchard plot 
analysis. Cells were incubated with different concentrations of 125I- 
labelled CD2 2  for 2  h. Afterwards cells were washed twice and 
radioactivity was measured. Mean of three experiments which were 
performed in duplicate is shown; SDs were less than 10%. The cell 
lines are depicted by numbers: KM3 [1]; Daudi [2]; Raji [3]; Ramos 
[4]; R osl [5]; DoHH2 [6] and SU-DHL - 6  [7].
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Table 2. CD22-ricin A protein synthesis inhibiting activity in 
comparison with the number of internalized molecules
Cell line
Inhibition of 
protein synthesis (%)a 
-N H 4CI + NH 4CI
Internalized mol./cellb 
-N H 4CI + NH 4CI
KM3
lh 64 97 20 300 17 800
24 h 81 100 69 900 60 700
Daudi
lh 74 93 33 000 38 700
24 h 87 100 110300 106400
Ramos
1 h 100 100 52000 46900
24 h 100 1 0 0 154 500 159 300
a Inhibition of protein synthesis was determined as decribed in 
Materials and Methods in rate of cytotoxicity. Experiments were 
performed in triplicate and mean of three experiments is shown. SDs 
were less than 5 %.
bThe numbers of internalized molecules/cell were determined as 
described in Materials and Methods in kinetics of binding and 
internalization of 125I-CD22. Mean of three experiments which 
were performed in duplicate is shown; SDs were less than 10%.
Rate o f cytotoxicity
To study the influence of the incubation time on the 
cytotoxicity of CD22-ricin A in relation to the antigen 
density, the rate of protein synthesis inhibition was deter­
mined in the lines Daudi, KM3 and Ramos, which varied in 
antigen density and susceptibility to cytotoxicity. Cells were 
incubated with 10~8M IT during various periods of time 
followed by an IT-free incubation up to 24h after initiating 
the experiment. This procedure was used to exclude
differences in cytotoxicity due to the delay in action of the 
IT by binding to and transport into the cell. The kinetics in 
Daudi and K M 3 were comparable. Both cell lines showed a 
fast inhibition of protein synthesis within 1 h of incubation 
(respectively 74% and 64%). Thereafter inhibition rate 
slowed down for up to 24 h (Table 2). In contrast, protein 
synthesis in Ramos was blocked completely within lh  of 
incubation even in absence of NH4C1 (Table 2). In presence of 
N H 4CI the incubation time to block protein synthesis com­
pletely in Daudi and KM3 was reduced from more than 24 h 
to 8 and 2 h, respectively (data not shown).
Kinetics o f  internalization and intracellular degradation of 
125 LCD 22
To investigate the relation between cytotoxicity of CD22- 
ricin A and the number of internalized molecules, the kinetics 
of internalization and intracellular degradation were studied 
by means of 10“ 8 M 125I-labelled CD22 in Daudi, KM3 and 
Ramos. After an initial binding phase the number of mol­
ecules bound to the cell membrane at 4°C did not change in 
KM3 and Ramos up to 24 h. In Daudi a slight decrease of 
bound molecules was detected (Fig. 2). In contrast to Daudi 
and KM3 in Ramos a discrepancy was found between the 
number of bound molecules (40 000) and the antigen density 
determined by Scatchard analysis (52000). This was due to 
the not completely saturating conditions of incubation with 
10~8M IT for Ramos as determined in the Scatchard 
analysis. This, however, did not count for Daudi and KM3. 
The number of bound molecules per cell at 37°C was four to 
five times less for K M 3 in comparison with Daudi and 
Ramos. This disagreed with the difference in antigen density 
of seven to eight times fewer antigen molecules when com­
pared with Daudi and Ramos. This may be explained partly 
by the non-saturation conditions for Ramos and by
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Fig. 2 . Binding of l25I-CD22 during continuous incubation and internalization. Cells were incubated at 37°C ( • )  and 4°C (O) for various 
periods of time with 10“ 8M CD22 at 37°C and at 4°C as described in Materials and Methods. The number of surface-bound molecules 
was measured by counting cell-bound radioactivity that was removable by glycine buffer pH 2. Mean of three experiments which were 
performed in duplicate is shown; SDs were less than 10%.
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Fig. 3. Internalization of 125I-CD22. The intracellular number of molecules was measured by counting cell-bound radioactivity that was 
not removable by glycine buffer pH 2 (H). The number of internalized and subsequently degraded and exocytosed molecules was measured 
by counting TCA-soluble radioactivity of the supernatant of incubation medium (□). The absolute amount of internalized molecules was 
determined as the sum of intracellular molecules and intracellular molecules that were degraded and subsequently exocytosed (O). Mean of 
three experiments which were performed in duplicate is shown; SDs were less than 1 0 %. Internalization of i25I~CD22 was determined in 
absence (A) and in presence (B) of 6 mM NH4C1.
differences in internalization and/or re-expression of 
antigen.
In absence of NH4C1 the course of the kinetics of inter­
nalization of CD22 (defined as the sum of the intracellular 
amount of CD22 and the amount of intracellularly degraded 
and subsequently exocytosed CD22) in Daudi, KM3 and 
Ramos were comparable (Fig. 3A). After 2h the intracellu­
lar amount of CD22 was maximal. Thereafter the intracel­
lular amount of CD22 remained high in KM 3 and Ramos, 
whereas in Daudi a reduction of CD22 was found. This 
suggest a difference in intracellular handling of CD22 or a 
difference in internalization of antigen-antibody complexes.
For all cell lines degradation and exocytosis of CD22 could 
be determined after 1 h of incubation. However, the degrada­
tion rate in Daudi and Ramos was at least twice as high as in 
KM3 notwithstanding the intracellularly present amount of 
CD 22, also suggesting a different intracellular handling.
All these cell lines showed a very fast internalization of
CD22 during the first hour whereafter the internalization rate 
slowed down but the total number of internalized CD22 
increased up to at least 24h. Although Ramos internalized 
the highest number of CD22 within 24 h, KM3 internalized
11.8 times more CD22 than the available antigen (70000 
molecules CD22 per 5 900 molecules antigen) whereas Daudi 
and Ramos internalized respectively 2.6 and 3.0 times more 
CD22 than the available antigen. This suggests a difference in 
the mean internalization activity of the CD22 antigens on the 
varying B cell lines.
The number of internalized molecules seemed to be related 
to cytotoxicity. However, this was rejected by close analysis 
of the data (Table 2) since 52000 molecules internalized by 
Ramos inhibited protein synthesis more (100%) than 69900 
and 110300 molecules internalized by respectively KM3 
(81%) and Daudi (87%).
Addition of N H 4C1 did not influence the total amount 
of internalized CD22 (Fig. 3B). Intracellular degradation,
©  1995 Blackwell Science Ltd, Scandinavian Journal o f Immunology, 41, 563-569
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however, was delayed from within 2 to approximately 8 h. A 
higher cytotoxic potency of CD22-ricin A due to NH4CI 
could not be explained by a higher amount of internalized 
molecules, but by a reduced degradation rate during the first 
hours of treatment.
DISCUSSION
Three processes are underlying the cytotoxic activity of ricin 
A ITs. The MoAb moiety must bind to the specific target cell 
antigen. This binding has to be followed by an internalization 
of the IT. After splicing from the MoAb the ricin A must be 
translocated to the cytosol where it will affect the ribosomal 
activity resulting in an irreversible inhibition of protein 
synthesis [5, 20, 21]. In different B cell lines we investigated 
which factors contribute most to the cytotoxic activity of 
CD22-ricin A IT. For the production of the IT we used 
aglycosyl recombinant ricin A that already has been used 
for in vivo studies in mice [22].
In absence and presence of the lysosomotropic amine 
NH4CI, that enhances cytotoxicity of ricin A ITs [19, 23], 
we found no correlation between antigen density and cyto­
toxicity ofCD22-ricin A. The antigen density on the cell lines, 
determined by Scatchard analysis, varied from 5 900 to 60 400 
molecules per cell. CD22-ricin A appeared to be highly 
cytotoxic even to cells expressing low numbers of antigen 
such as KM3. Cytotoxicity expressed by ID 50 values varied 
from 2.1x10“ 12 M to 3,8xl0“ n M in absence of NH 4CI and 
from 2.8x10“ 14 to 5.2x10“ 12 M in presence of 6 mM NH 4C1.
Compared with CD22-ITs used by other investigators our 
CD22-recombinant ricin A IT appears to be more cytotoxic 
to Daudi (ID50 4,2x10“ 12 M) than H D 6 -native ricin A 
(3.7xl0“ n M [24] and L3xl0“ n M [25]), HD 6 -deglycosy- 
lated ricin A (1.4xl0“ u M [24]), UV22-l-native ricin A 
(2.1xl0“ n M [25]) and UV22-2-native ricin A (3.8xlO~n M 
[25]), but less toxic than RFB4-native ricin A (1.2x10“ 12 M 
[25]) and RFB4-deglycosylated ricin A (1.2x10” 12M [25, 
26]). These differences may be due to recognition of different 
epitopes by the CD22-MoAbs, to the ricin A variants, to 
variations in Daudi lines in the different laboratories and to 
different experimental procedures.
We investigated also the relationship between antigen 
density and cytotoxicity after shorter incubation periods. 
For this reason we studied the rate of cytotoxicity of 10” 8M 
IT in cell lines which vary in antigen density and susceptibility 
to CD22-ricin A. We did not find a correlation. The rate of 
cytotoxicity in KM3 was comparable with those in Daudi 
which bound 7-times more CD22. Protein synthesis in Ramos,
a
which bound CD22 at the same level as Daudi, was completely 
inhibited after 1 h whereas in Daudi only 87% was inhibited 
after 24 h. N H 4CI reduced the time required for complete 
inhibition by 10“ 8 M IT in Daudi and KM3 from longer than
24 h to 8 and 2h, respectively. These results suggest that the 
antigen density is not the most important factor for the cyto­
toxic efficacy of CD22~ricin A. This implies that patients with
B cell malignancies expressing low numbers of CD22 antigens 
should also be considered for CD22-ricin A treatment.
Subsequently, we investigated whether the cytotoxicity of 
CD22-ricin A was related more to the amount of molecules 
internalized into the target cells. The internalization kinetics 
were related to the antigen density although variations in 
internalization are less pronounced than those in antigen 
density. The number of internalized CD22 molecules per 
antigen molecule within 24 h was higher in KM 3 (11.8 
molecules) than in Daudi and Ramos (2.6 and 3.0 molecules, 
respectively). This suggests differences in the mean internaliz­
ation activity of the antigen on the varying cell lines. The total 
amount of internalized CD22 exceeded the number of mol­
ecules that could be maximally bound implying that the antigen 
for CD22 was re-expressed or newly synthesized after binding.
The number of internalized molecules did not correlate 
with the cytotoxic activity of the IT. Within 24 h Daudi 
internalized twice as many molecules as KM3 (Table 2) 
whereas inhibition of protein synthesis was comparable 
(87% and 81%, respectively; Table 2). Within 1 h of incu­
bation Ramos internalized 52000 molecules resulting in a 
complete blocking of protein synthesis (Table 2). In contrast 
Daudi internalized 110 300 molecules during 24 h which 
resulted in only 87% inhibition (Table 2). These results 
indicate differences in intracellular processing of CD22-ricin 
A which influences strongly the cytotoxic activity.
Treatment of cells with NH 4C1 increases the endosomal pH 
[27], resulting in reduction of endosomal proteolysis of IT 
[23]. This induces a higher chance on translocation of ricin A 
over the endosomal/lysosomal membrane resulting in an 
improvement of IT activity. We showed that N H 4CI induced 
a delay of intracellular degradation of IT which increased 
cytotoxicity of CD22-ricin A. These data show that intracel­
lular processing is essential for the cytotoxicity of ricin A ITs.
The importance of intracellular routing for the potency of 
ricin A ITs is supported by findings of other authors. It is 
found that cytotoxicity of ricin A ITs also can be increased by 
addition of the endoplasmatic reticulum retention signal, 
KDEL, to the carboxyl terminus of the ricin A-chain [28, 
29]. The KDEL facilitates ricin A entry into the cytosol by 
interaction with the intracellular KDEL receptor which 
promotes transport of the toxin to the endoplasmatic reticu­
lum, where translocation into the cytosol occurs.
We conclude that the CD22-ricin A IT has a high cytotoxic 
potency even for cells expressing low numbers of antigen 
molecules. The intracellular routing of the IT is a major factor 
for the cytotoxicity of CD22-ricin A. Investigations elucidat­
ing the involvement of the activation state of the antigen are 
in progress. Patients suffering from B cell malignancies 
expressing low numbers of CD22 antigens should also be 
considered for treatment with CD2 2 -ricin A.
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